Innovation and Translation Support
The Innovation and Translation Support Service harnesses MCHRI & Stanford’s offerings to reduce funding gaps, regulatory burden, and challenges with identifying collaborators in translational medicine.
How This Is Achieved
How We Prioritize Projects
Take referrals from MCHRI Executive Leadership and identify projects that align with SMCH Goals
Look for opportunities to partner with investigators at Project Concept, Study Design, and Pre-Award phases
Provide support for projects that do not have a direct path for patent licensure, struggle finding funding, and require industry collaboration
Services We Support
Assessment
MCHRI supports investigators with streamlining product development, reducing risk and increasing valuation, including:
Regulatory Strategy
Target Profile Development
Path from Bench to Bedside
Market Assessment
Existing/Competing Solutions
Market Sizing and Clinical Impact
Project Management
Timeline Development
Budget Building/Tracking
Education
MCHRI designs and coordinates educational opportunities to benefit translational medicine scientists at Stanford, featuring:
Career Development
Eureka Certificate Course in Translational Medicine
Drug & Device Development (D3) Training
Topic Discussions
Webinars and Live Presentations
Facilitation
MCHRI guides health innovations through the regulatory and medical development landscapes, including:
Regulatory Interactions
IND/IDE Preparation and Maintenance
Funding Opportunities
Exploration and Evaluation
Innovation
Business Development
Engagement with VC and Industry
Funding
MCHRI partners with existing seed programs and philanthropic sources to establish new collaborations and support grant applications
Contact
Grant Wells, MS
Director of Innovation & Development
gwells2@stanford.edu